Overcoming genetic drivers in alopecia areata: Hair regrowth in a patient with AIRE gene mutation (APECED syndrome) treated with ruxolitinib

Key Points

• The research aims to explore the effects of ruxolitinib on hair regrowth in a patient with alopecia areata related to an AIRE gene mutation.
• Reported a case of a patient with alopecia areata and AIRE gene mutation
• Administered ruxolitinib (a Janus kinase inhibitor) as treatment
• Monitored hair regrowth outcome post-treatment
• Patient experienced complete hair regrowth
• Demonstrated effectiveness of JAK inhibitors in genetic forms of alopecia areata
• Highlights potential for treatment in sporadic alopecia areata as well